Jing Ning

Jing Ning is a Senior Professor at The University of Texas MD Anderson Cancer Center. Her research integrates biostatistics and oncology, focusing on statistical methodology for cancer research, particularly hematological malignancies and leukemia. Recent work includes developing risk stratification models for hepatocellular cancer, shape-restricted modeling for breast cancer prognosis, and biomarker-guided clinical trial designs. She has contributed to precision medicine through conformal predictive intervals in survival analysis and evaluated novel therapies, including menin inhibitors for acute leukemias. Her collaborative research spans pathology, including Merkel cell carcinoma markers, and clinical outcomes in ophthalmologic cancers.